Blog

FDA approves Pfizer, German Merck immunotherapy for skin cancer – KFGO


FiercePharma

FDA approves Pfizer, German Merck immunotherapy for skin cancer
KFGO
(Reuters) – U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. The Food and Drug Administration said
Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy BavencioFiercePharma



all 15 news articles »

2017-03-23 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.